Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$2.46 - $8.74 $34,321 - $121,940
-13,952 Closed
0 $0
Q3 2021

Jun 21, 2023

BUY
$5.1 - $9.39 $71,155 - $131,009
13,952 New
13,952 $119,000
Q3 2021

Mar 30, 2023

SELL
$5.1 - $9.39 $33,813 - $62,255
-6,630 Reduced 32.21%
13,952 $119,000
Q3 2021

Nov 15, 2021

SELL
$5.1 - $9.39 $33,813 - $62,255
-6,630 Reduced 32.21%
13,952 $119,000
Q2 2021

Jun 21, 2023

BUY
$3.95 - $6.88 $81,298 - $141,604
20,582 New
20,582 $131,000
Q2 2021

Mar 30, 2023

BUY
$3.95 - $6.88 $81,298 - $141,604
20,582 New
20,582 $131,000
Q2 2021

Aug 16, 2021

BUY
$3.95 - $6.88 $81,298 - $141,604
20,582 New
20,582 $132,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.